DNA Delivery Systems for Gene Therapies
Dr. Vivienne Raper has written an excellent FutureLab/Biocompare editorial comparing the various...
Dr. Vivienne Raper has written an excellent FutureLab/Biocompare editorial comparing the various...
The FDA has approved 12 gene therapies so far, and the agency's top drug regulator wants to see the...
SIRION Biotech products and services are now part of the Revvity portfolio!
rAAV vectorology is being optimized to allow for highly specific expression and greater efficacy –...
SIRION Biotech, a global supplier of high-quality AAV vectors, has expanded its staff to meet the...
SIRION Biotech has ongoing research and licensing agreements with several global pharma and biotech...
ISO Certification requires ongoing audits to assure that the company is maintaining ISO standards...
SIRION Biotech is now part of the Revvity portfolio!
SIRION Biotech licences its LentiBOOST® transduction technology to Cellectis
AAV Webinar
On Demand
CAR-TCR Summit
August 29 - September 1, Boston
Meet Benjamin Eberhardt, LentiBOOST Product Manager! Eberhardt@sirion-biotech.com
Japan Society of Cell and Gene Therapy
September 11 - September 13, Osaka
BIOJapan
October 11 - October 13, Yokohama